Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuping Li

Showing results (421-430 of 436) with videos related to

Pageof 44
Sort By:
Leukemia|June 13, 2022
Genomic profiling identifies distinct genetic subtypes in extra-nodal natural killer/T-cell lymphomaGehong Dong, Xuxiang Liu, Lifu Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2021
Double-hit Signature with <i>TP53</i> Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOPJoo Y Song, Anamarija M Perry, Alex F Herrera, et al.
Cell Systems|February 16, 2021
TAMEP are brain tumor parenchymal cells controlling neoplastic angiogenesis and progressionRoland E Kälin, Linzhi Cai, Yuping Li, et al.
Blood|May 31, 2022
DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOSTyler A Herek, Alyssa Bouska, Waseem Lone, et al.
The Journal of Experimental Medicine|April 28, 2026
Tet2 deficiency alters CD4+ T cell function and promotes T cell lymphoma with a TFH cell immunophenotypeTayla B Heavican-Foral, Yuping Li, Waseem Lone, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 30, 2023
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK-029A in Treatment-Naive Patients With Advanced NSCLC Harboring EGFR Exon 20 Insertion Mutations: A Phase 1 TrialJianchun Duan, Lin Wu, Kunyu Yang, et al.
Science Advances|October 17, 2025
Cooperative role of distinctive TP53 and PTEN combined loss in the peripheral T cell lymphoma-GATA3 molecular subgroupWaseem G Lone, Jiayu Yu, Xuxiang Liu, et al.
Targeted Oncology|November 7, 2019
Dynamics of Plasma EGFR T790M Mutation in Advanced NSCLC: A Multicenter StudyZhengquan Yang, Jialu Li, Yujie Hu, et al.
Journal of Evidence-Based Medicine|April 1, 2025
Expert Consensus on Perioperative Physician-Pharmacist Airway Co-ManagementDongmei Meng, Yuan Qiu, Shiyue Li, et al.
Cancer Communications (London, England)|October 26, 2021
Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first-line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open-label, parallel controlled clinical studyJie Zhang, Yueyin Pan, Qin Shi, et al.
Pageof 44

Showing results (421-430 of 436) with videos related to

Sort By:
Pageof 44
Leukemia|June 13, 2022
Genomic profiling identifies distinct genetic subtypes in extra-nodal natural killer/T-cell lymphomaGehong Dong, Xuxiang Liu, Lifu Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2021
Double-hit Signature with <i>TP53</i> Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOPJoo Y Song, Anamarija M Perry, Alex F Herrera, et al.
Cell Systems|February 16, 2021
TAMEP are brain tumor parenchymal cells controlling neoplastic angiogenesis and progressionRoland E Kälin, Linzhi Cai, Yuping Li, et al.
Blood|May 31, 2022
DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOSTyler A Herek, Alyssa Bouska, Waseem Lone, et al.
The Journal of Experimental Medicine|April 28, 2026
Tet2 deficiency alters CD4+ T cell function and promotes T cell lymphoma with a TFH cell immunophenotypeTayla B Heavican-Foral, Yuping Li, Waseem Lone, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 30, 2023
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK-029A in Treatment-Naive Patients With Advanced NSCLC Harboring EGFR Exon 20 Insertion Mutations: A Phase 1 TrialJianchun Duan, Lin Wu, Kunyu Yang, et al.
Science Advances|October 17, 2025
Cooperative role of distinctive TP53 and PTEN combined loss in the peripheral T cell lymphoma-GATA3 molecular subgroupWaseem G Lone, Jiayu Yu, Xuxiang Liu, et al.
Targeted Oncology|November 7, 2019
Dynamics of Plasma EGFR T790M Mutation in Advanced NSCLC: A Multicenter StudyZhengquan Yang, Jialu Li, Yujie Hu, et al.
Journal of Evidence-Based Medicine|April 1, 2025
Expert Consensus on Perioperative Physician-Pharmacist Airway Co-ManagementDongmei Meng, Yuan Qiu, Shiyue Li, et al.
Cancer Communications (London, England)|October 26, 2021
Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first-line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open-label, parallel controlled clinical studyJie Zhang, Yueyin Pan, Qin Shi, et al.
Pageof 44